HRA Pharma Cicatridine 10 Vaginal Ovules

Box of 10 vaginal ovules
£455.00 per kg/L
In stock
Delivery at home
From June 3rd, 2020
View all the delivery methods for this item
Country of delivery:
Hermes Delivery 4 to 8 days is £5.50
Free from £45
DPD Delivery 3 to 7 days is £5.99
Free from £49
Chrono Classic Delivery 2 to 3 days is £9.50
Free from £99
DHL Express Delivery 1 to 2 days is £15.99
Free from £299
By buying this product, I benefit from:
£0.18 on my loyalty card
HRA Pharma Cicatridine 10 Vaginal Ovules is proposed to support the wound healing of vulvo-vaginal lesions from any origin:
- Infections, in particular vulvo-vaginal mycoses,
- Childbirth (Postpartum dyspareunia),
- Colposcopy,
- Conization,
- Chemotherapy,
- Radiotherapy,
- Surgery,
- Trauma.

Healing, protective and lubricating vaginal mucous membrane, Cicatridine contains no hormonal substance and also allows an optmal treatmet of vaginal dryness.

10 vaginal ovules of 2 g.
Vaginal mycosis: An ovule per day during 5 to 10 days after the antimyicosic treatment.

Postpartum dyspareunia, post-conization and post-colposcopy lesions, post-radic or post-surgical lesion and other lesions: An ovule per day during 5 to 10 days according to the extent of the lesions.

Vaginal dryness: Two ovules per week uninterrupted.
Indication: Healing of the vulvovaginal wounds, from all origin.
EAN Code 3401079135193
Presentation Box
Contents 10 vaginal ovules
Advised to Vagina healing
Last reviews on this item
HRA Pharma Cicatridine 10 Vaginal Ovules

Discover the brand HRA Pharma

HRA Pharma is devoted to innovation in women health treatments (treatment of unsatisfied medical needs) and endocrinology.

Its unique know-how in research and innovation allows it to develop products of the future, accessible to everyone and everywhere in the world.

HRA Pharma creates the best treatments in terms of quality, efficiency and safety thanks to its capacity in research.


Continuing your navigation, you accept the use of cookies that will allow us to offer contents and advertising linked to your interests.

Learn more
Subscribe to the newsletter to benefit from our privilege offers